The University Hospital

Dr. rer. nat. Kevin Bode

Immunmonitoring

E-mail address: kevin.bode@med.uni-tuebingen.de

PhD in Biology, Heidelberg University

Immunologist specializing in the molecular mechanisms governing immune tolerance and adaptive immunity. Possesses robust expertise in tumor immunology and autoimmunity, with a focus on dissecting immune cell interactions and regulatory signaling pathways. Actively engaged in pioneering cellular therapies for oncology and type 1 diabetes, leveraging advanced single-cell technologies to develop personalized immunotherapeutic strategies.
LinkedIn Profile

2010-2015

B.Sc. and M.Sc. in Molecular Biology at University of applied Sciences, Germany
2015-2020

PhD Student and Postdoctoral Fellow at DKFZ Heidelberg and Heidelberg University, Germany
2020-2024

Postdoctoral Fellow at Harvard Medical School and Joslin Diabetes Center, Boston, USA
2025

Project Lead Immunmonitoring, DKTK partner site Tübingen, Childrens Hospital University Tübingen

Bode K, Bujupi F, Link C, Hein T, Zimmermann S, Peiris D, Jaquet V, Lepenies B, Weyd H, Krammer PH. Dectin-1 Binding toAnnexins on Apoptotic Cells Induces Peripheral Immune Tolerance via NADPH Oxidase-2. Cell Rep. 2019 Dec 24;29(13):4435-4446.e9. doi: 10.1016/j.celrep.2019.11.086.
Bode K, M Hauri, V Jaquet, H Weyd. Unlocking the power of NOX2: A comprehensive review on its role in immuneregulation. Redox Biology, 2023. https://doi.org/10.1016/j.redox.2023.102795.
Bode K, MacDonald T, Stewart T, Mendez B, Cai EP, Morrow N, Lee YC, Yi P, Kissler S. Protective Renalase-deficiency in betacells shapes immune metabolism and function in autoimmune diabetes. Diabetes; 72(8):1127–1143 (2023).
Bode K, Wei S, Gruber I, Li J, Kissler S, Yi P. Beta cells deficient for Renalase counteract autoimmunity by shaping naturalkiller cell activity. Front Immunol. 2024 Jun 4;15:1403752. doi: 10.3389/fimmu.2024.1403752. PMID: 38975343; PMCID:PMC11225407.
Google Scholar Profile